H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 137 Citations 58,648 639 World Ranking 748 National Ranking 457

Research.com Recognitions

Awards & Achievements

2005 - Member of the National Academy of Medicine (NAM)

Overview

What is he best known for?

The fields of study he is best known for:

  • Cancer
  • Internal medicine
  • Radiology

Nuclear medicine, Positron emission tomography, Radiology, Pathology and Internal medicine are his primary areas of study. His study in Nuclear medicine is interdisciplinary in nature, drawing from both Lesion, Lung cancer and Breathing. His research integrates issues of Stage, Tomography, Magnetic resonance imaging and Metastasis in his study of Positron emission tomography.

His work deals with themes such as Mesothelioma and Carcinoma, which intersect with Radiology. His studies in Pathology integrate themes in fields like Radioimmunotherapy, Melanoma, Antibody, Radiation therapy and In vivo. The Internal medicine study combines topics in areas such as Endocrinology, Surgery and Oncology.

His most cited work include:

  • Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. (775 citations)
  • Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials (597 citations)
  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer (530 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Nuclear medicine, Positron emission tomography, Internal medicine, Pathology and Radiology. The concepts of his Nuclear medicine study are interwoven with issues in Lesion, Prostate cancer and Biodistribution. The study incorporates disciplines such as Tomography and Magnetic resonance imaging in addition to Positron emission tomography.

His work investigates the relationship between Internal medicine and topics such as Oncology that intersect with problems in Clinical trial. His Pathology research incorporates elements of Radioimmunotherapy, Antibody, Monoclonal antibody, Colorectal cancer and In vivo. His work carried out in the field of Radiology brings together such families of science as Metastasis and Thyroid cancer.

He most often published in these fields:

  • Nuclear medicine (35.39%)
  • Positron emission tomography (21.33%)
  • Internal medicine (21.09%)

What were the highlights of his more recent work (between 2013-2021)?

  • Prostate cancer (20.96%)
  • Nuclear medicine (35.39%)
  • Biodistribution (14.18%)

In recent papers he was focusing on the following fields of study:

His primary areas of investigation include Prostate cancer, Nuclear medicine, Biodistribution, Cancer research and Internal medicine. His Prostate cancer study combines topics from a wide range of disciplines, such as Positron emission tomography, Radiology and Prostate. Steven M. Larson has researched Positron emission tomography in several fields, including Biopsy, Pathology and Glutamate carboxypeptidase II.

His Nuclear medicine research is multidisciplinary, incorporating elements of Lesion, Repeatability and Reproducibility. Steven M. Larson has included themes like Cancer, Radioimmunotherapy, Monoclonal antibody, Pretargeted Radioimmunotherapy and Antigen in his Cancer research study. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Surgery and Oncology.

Between 2013 and 2021, his most popular works were:

  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe (377 citations)
  • Radioimmunotherapy of human tumours (215 citations)
  • The epichaperome is an integrated chaperome network that facilitates tumour survival (126 citations)

In his most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiology

Steven M. Larson focuses on Prostate cancer, Nuclear medicine, Cancer research, Biodistribution and Radiology. The various areas that Steven M. Larson examines in his Prostate cancer study include Positron emission tomography, Prostate and Oncology. Steven M. Larson combines subjects such as Biopsy, Pathology, Magnetic resonance imaging and Radiation treatment planning with his study of Positron emission tomography.

His Nuclear medicine research includes elements of Lesion and Chemotherapy. His studies deal with areas such as Cancer, Radioimmunotherapy, Antibody, Immunology and Internalization as well as Cancer research. His Cancer study combines topics in areas such as Computational biology and In vivo.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

C.Clifton Ling;John Humm;Steven Larson;Howard Amols.
International Journal of Radiation Oncology Biology Physics (2000)

1225 Citations

Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

Renier J. Brentjens;Jean Baptiste Latouche;Elmer Santos;Francesc Marti.
Nature Medicine (2003)

816 Citations

Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials

Lalitha K. Shankar;John M. Hoffman;Steve Bacharach;Michael M. Graham.
The Journal of Nuclear Medicine (2006)

758 Citations

Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza.
Clinical Cancer Research (2007)

704 Citations

Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher.
Clinical Cancer Research (2005)

699 Citations

Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding.

Yusuf E. Erdi;O. Mawlawi;Steven M. Larson;M. Imbriaco.
Cancer (1997)

676 Citations

Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

Richard J. Robbins;Qiang Wan;Ravinder K. Grewal;Roland Reibke.
The Journal of Clinical Endocrinology and Metabolism (2006)

599 Citations

Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

Renier J. Brentjens;Elmer Santos;Yan Nikhamin;Raymond Yeh.
Clinical Cancer Research (2007)

586 Citations

Targeted α particle immunotherapy for myeloid leukemia

Joseph G. Jurcic;Steven M. Larson;Steven M. Larson;George Sgouros;Michael R. McDevitt;Michael R. McDevitt.
Blood (2002)

539 Citations

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

Miriam Benezra;Oula Penate-Medina;Pat B. Zanzonico;David Schaer.
Journal of Clinical Investigation (2011)

537 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Steven M. Larson

Sanjiv S. Gambhir

Sanjiv S. Gambhir

Stanford University

Publications: 157

Andrew M. Scott

Andrew M. Scott

La Trobe University

Publications: 138

Wim J.G. Oyen

Wim J.G. Oyen

Humanitas University

Publications: 138

Jason S. Lewis

Jason S. Lewis

Memorial Sloan Kettering Cancer Center

Publications: 134

Abass Alavi

Abass Alavi

University of Pennsylvania

Publications: 130

David M. Goldenberg

David M. Goldenberg

Pennsylvania State University

Publications: 114

Nai-Kong V. Cheung

Nai-Kong V. Cheung

Memorial Sloan Kettering Cancer Center

Publications: 113

Rodney J. Hicks

Rodney J. Hicks

Peter MacCallum Cancer Centre

Publications: 108

David A. Mankoff

David A. Mankoff

University of Pennsylvania

Publications: 99

Richard L. Wahl

Richard L. Wahl

Washington University in St. Louis

Publications: 97

Vladimir Tolmachev

Vladimir Tolmachev

Uppsala University

Publications: 93

Michel Sadelain

Michel Sadelain

Memorial Sloan Kettering Cancer Center

Publications: 88

George Sgouros

George Sgouros

Johns Hopkins University

Publications: 87

Martin G. Pomper

Martin G. Pomper

Johns Hopkins University School of Medicine

Publications: 86

Jorge A. Carrasquillo

Jorge A. Carrasquillo

Memorial Sloan Kettering Cancer Center

Publications: 83

Jeffrey Schlom

Jeffrey Schlom

National Institutes of Health

Publications: 83

Something went wrong. Please try again later.